AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch

Category: Health and Policy

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings
22.03.2024

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings

In an unprecedented move, GlaxoSmithKline has retracted patent listings for Advair, Flovent, and Ventolin from the FDA’s Orange Book. This decision came after the FTC's scrutiny over non-inventive patent listings intensified, affecting several pharmaceutical companies aiming to maintain market exclusivity.
Arlen Fairweather
by Arlen Fairweather
  • Health and Policy
  • 0

Categories

  • Health and Wellness (29)
  • Medications (14)
  • Health and Medicine (9)
  • Pharmacy and Medications (6)
  • Skincare (4)
  • Legal (3)
  • Health and Fitness (2)
  • Business (2)
  • Health (2)
  • Health and Policy (1)

Latest posts

6 Effective Alternatives to Neurontin for Managing Pain and Seizures
The Role of Ibrutinib in Treating Chronic Lymphocytic Leukemia
The Connection Between Discoid and Systemic Lupus Erythematosus and the Immune System
Top Alternative Options to Canada Meds Now in 2025
GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings

Archives

  • July 2025 (7)
  • June 2025 (3)
  • May 2025 (3)
  • April 2025 (4)
  • March 2025 (4)
  • February 2025 (3)
  • January 2025 (4)
  • December 2024 (2)
  • October 2024 (2)
  • September 2024 (1)
  • August 2024 (1)
  • July 2024 (1)
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
© 2025. All rights reserved.